Beijing Dikang Pharmaceutical Investment Management Co., Ltd. was founded in 2014, located in Zhongguancun Park, Daxing Pharmaceutical Industrial Park, Beijing.The company provides medical manufacturing enterprises and biotechnology companies with one-stop Tissue Engineering and Regenerative Medicine Contract Development and Manufacturing solutions, including research and development, product testing, animal testing, clinical trials, product registration and contract manufacturing, which it greatly reduces the investment cost and compliance risk before the sale of products of science and innovation enterprises, realises the whole process of product development to manufacturing, and creates new value for health continuously.The company has 3000 square metres of GMP clean workshop and R&D laboratory, including 10,000, 100,000 and local 100-level workshop purification area, and planning a variety of space for production area, experimental area, storage area and office area. A team of experts from Academy of Military Medical Sciences and Beijing Jiaotong University serves as technical consultants, and the company establishes a perfect quality management system for R&D and manufacturing to meet the R&D and manufacturing of various biomaterial medical devices, including various types of injections, dressings, gels, creams, lyophilised powder, and other different dosage forms of products.

The Tissue Engineering and Regenerative Medicine Biomaterials Laboratory The Healtech CDMO plantfrom undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.The company provides medical manufacturing enterprises and biotechnology companies with one-stop Tissue Engineering and Regenerative Medicine Contract Development and Manufacturing solutions, including research and development, product testing, animal testing, clinical trials, product registration and contract manufacturing, which it greatly reduces the investment cost and compliance risk before the sale of products of science and innovation enterprises, realises the whole process of product development to manufacturing, and creates new value for health continuously.

Dikang Pharma has 3000 square metres of GMP clean workshop and R&D laboratory, including 10,000, 100,000 and local 100-level workshop purification area, and planning a variety of space for production area, experimental area, storage area and office area. The company has built a number of independent medical device production lines, strictly adhering to the ISO 9001 and ISO 13485 standards to establish a comprehensive R & D and production quality management system. Through an experienced and professional production management team, we strengthen the production quality control and process management, focus on compliance as our top priority, and provide high quality and reassuring contract manufacturing services with high standard requirements.The company meets the R&D and manufacturing of various biomaterial medical devices, including various types of injections, dressings, gels, creams, lyophilised powder, and other different dosage forms of products.